Navigation Links
Bode Technology Sponsors Houston Forensic Science Center Event
Date:8/12/2014

Lorton, VA (PRWEB) August 12, 2014

The Bode Technology Group, Inc. (Bode), a leading provider of forensic services that recently completed DNA testing for more than 5,000 untested sexual assault kits for the city of Houston, is co-sponsoring Houston Forensic Science Center’s event tonight. This presentation of the story of DNA from a legal and genetics perspective in Houston, featuring Dr. C. Thomas Caskey and Attorney Rusty Hardin highlights the first forensic DNA case tried in court in Texas and is being held in conjunction with National Forensic Science Week.

Dr. Caskey was the inventor on a patent for DNA typing using the STR identification technique that has become the gold standard for DNA testing in criminal cases. Rusty Hardin, who relied on Dr. Caskey as a key witness, was the prosecutor for the first case brought to trial using DNA technology.

“We are proud to support this event. Dr. Caskey and Mr. Hardin’s work have helped shape what we are able to accomplish today in testing forensic DNA cases worldwide. DNA evidence is one of law enforcement’s best weapons to fight crime,” said Andrew Singer, Vice President of Sales and Marketing at Bode. “In addition, the efforts of the entire city of Houston should be recognized as a model approach to eliminating the backlog of untested sexual assault kits throughout the country.”

The city of Houston recently announced that they have successfully eliminated a backlog of more than 10,000 untested sexual assault kits. Their victim-centric approach created a collaborative team who ensured the kits were tested and the results were investigated, and now see to the prosecution of these cases in an effort to continue prioritizing the well-being of assault survivors.

Currently, there are an estimated 400,000 untested kits in crime laboratories and police departments across the country. Bode is working hard to support the efforts of those communities where backlogs have been identified.

Bode’s support is a part of week-long announcements and activities occurring during National Forensic Science Week.

About The Bode Technology Group, Inc.

Bode (http://www.bodetech.com) operates one of the most internationally respected private DNA laboratories and provides a comprehensive set of state-of-the-art forensic DNA collection products, DNA analysis services, and research services to law enforcement, the justice system and other government agencies around the world. Bode is one of the few private facilities worldwide to receive ISO/IEC 17025 accreditation from both the American Society of Crime Laboratory Accreditation Board (ASCLD/LAB-International Program) and the ANSI-ASQ National Accreditation Board/FQS for forensic testing.

Bode also provides immigration and paternity testing worldwide through subsidiary Chromosomal Labs • Bode Technology, which is accredited by AABB for Relationship Testing Activities.

Bode is one of the three wholly owned subsidiaries of SolutionPoint International, Inc. (http://www.solutionpoint-intl.com), a leading provider of business intelligence, security, compliance and monitoring, identity assurance, forensics, and situational awareness solutions for the commercial and government sectors on a worldwide basis.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12088788.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. Arizona State University engineers aim to improve performance of technology in extreme environments
4. iBioLaunch™ Technology Successfully Applied to Modified C1 Inhibitor
5. Pitt discoveries in quantum physics could change face of technology
6. Verenium to Present at Baird Clean Technology Conference
7. Puma Biotechnology Announces Completion of Private Placement
8. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
9. Animal Biotechnology - Technologies, Markets and Companies
10. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
11. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):